SOURCE: Advanced Plant Pharmaceuticals, Inc.,

February 17, 2010 12:06 ET

Advanced Plant Pharmaceuticals, Inc. Unveils Updated Strategic Plan to Relaunch Company in Alternative Energy Market Sector

Company to Address Financial Filings; Corporate Name Change and New CUSIP Number Pending

NEW YORK, NY--(Marketwire - February 17, 2010) -  Advanced Plant Pharmaceuticals, Inc. (PINKSHEETS: APPI) announced an updated strategic plan today to reinvent and renew the Company. The Company is in the process of implementing a new business plan to introduce to the market an innovative and industry leading alternative energy solution. Shareholders can expect announcements in the near future on the location of the company's new headquarter offices and a corporate name change.

In conjunction with the new business plan, investors can expect an overall public reporting clean-up with updated financials to be filed soon. The initial financial statements will be unaudited. The name change will include a new ticker symbol for the Company and a new CUSIP number. 

To be added to APPI's corporate e-mail list for shareholders and interested investors, please send an e-mail to

About Advanced Plant Pharmaceuticals, Inc.
Advanced Plant Pharmaceuticals, Inc. (APPI) focuses on the research and development of whole plant-based nutritionals. The company has a composition-oriented patent for a proprietary process of utilizing whole plants to safely manufacture all-natural nutritional supplements. APPI markets and distributes its line of products including Lo-Chol™ worldwide through various sales distribution channels.

About World Health Energy Inc.
World Health Energy, Inc., still known as Advanced Plant Pharmaceuticals to the financial markets, is an emerging renewable energy and biofuel company. The company will produce and market high-quality, low cost B100 Biodiesel to replace traditional fossil fuels.

"Safe Harbor Statement" Under The Private Securities Litigation Reform Act Of 1995

This press release contains forward-looking statements that involve risks and uncertainties. The statements in this release are forward-looking statements that are made pursuant to safe harbor provision of the Private Securities Litigation Reform Act of 1995. Actual results, events and performance could vary materially from those contemplated by these forward-looking statements. These statements involve known and unknown risks and uncertainties, which may cause Advanced Plant Pharmaceuticals, Inc.'s actual results in future periods to differ materially from results expressed or implied by forward-looking statements. These risks and uncertainties include, among other things, product demand and market competition. You should independently investigate and fully understand all risks before making investment decisions.

Contact Information

    Advanced Plant Pharmaceuticals, Inc.
    Investor Relations